Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Shares Outstanding: 2015-2020

Historic Shares Outstanding for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $126.4 million.

  • Outlook Therapeutics' Shares Outstanding rose 347.56% to $126.4 million in Q2 2020 from the same period last year, while for Jun 2020 it was $126.4 million, marking a year-over-year increase of 347.56%. This contributed to the annual value of $28.6 million for FY2019, which is 216.92% up from last year.
  • Latest data reveals that Outlook Therapeutics reported Shares Outstanding of $126.4 million as of Q2 2020, which was up 40.79% from $89.8 million recorded in Q1 2020.
  • In the past 5 years, Outlook Therapeutics' Shares Outstanding ranged from a high of $126.4 million in Q2 2020 and a low of $3.1 million during Q3 2017.
  • Moreover, its 3-year median value for Shares Outstanding was $20.0 million (2019), whereas its average is $35.5 million.
  • In the last 5 years, Outlook Therapeutics' Shares Outstanding crashed by 86.65% in 2018 and then surged by 663.21% in 2020.
  • Quarterly analysis of 5 years shows Outlook Therapeutics' Shares Outstanding stood at $23.6 million in 2016, then plummeted by 86.47% to $3.2 million in 2017, then soared by 233.29% to $10.6 million in 2018, then skyrocketed by 261.31% to $38.4 million in 2019, then spiked by 347.56% to $126.4 million in 2020.
  • Its last three reported values are $126.4 million in Q2 2020, $89.8 million for Q1 2020, and $38.4 million during Q4 2019.